REPCF closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, REPCF stock lost -90%.
REPCF is not paying dividends to its shareholders.
The last earnings report, released on Aug 04, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.03%, based on the last three reports.
Replicel Life Sciences Inc. has completed 1 stock splits, with the recent split occurring on Aug 10, 2016.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTCQB (USD).